1. Home
  2. ARRY vs CRGX Comparison

ARRY vs CRGX Comparison

Compare ARRY & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARRY
  • CRGX
  • Stock Information
  • Founded
  • ARRY 1989
  • CRGX 2021
  • Country
  • ARRY United States
  • CRGX United States
  • Employees
  • ARRY N/A
  • CRGX N/A
  • Industry
  • ARRY Semiconductors
  • CRGX
  • Sector
  • ARRY Technology
  • CRGX
  • Exchange
  • ARRY Nasdaq
  • CRGX Nasdaq
  • Market Cap
  • ARRY 855.4M
  • CRGX 633.3M
  • IPO Year
  • ARRY 2020
  • CRGX 2023
  • Fundamental
  • Price
  • ARRY $6.74
  • CRGX $15.05
  • Analyst Decision
  • ARRY Buy
  • CRGX Strong Buy
  • Analyst Count
  • ARRY 22
  • CRGX 6
  • Target Price
  • ARRY $12.61
  • CRGX $31.80
  • AVG Volume (30 Days)
  • ARRY 5.7M
  • CRGX 285.4K
  • Earning Date
  • ARRY 02-25-2025
  • CRGX 11-12-2024
  • Dividend Yield
  • ARRY N/A
  • CRGX N/A
  • EPS Growth
  • ARRY N/A
  • CRGX N/A
  • EPS
  • ARRY N/A
  • CRGX N/A
  • Revenue
  • ARRY $982,190,000.00
  • CRGX N/A
  • Revenue This Year
  • ARRY N/A
  • CRGX N/A
  • Revenue Next Year
  • ARRY $24.77
  • CRGX N/A
  • P/E Ratio
  • ARRY N/A
  • CRGX N/A
  • Revenue Growth
  • ARRY N/A
  • CRGX N/A
  • 52 Week Low
  • ARRY $5.15
  • CRGX $12.17
  • 52 Week High
  • ARRY $16.63
  • CRGX $33.92
  • Technical
  • Relative Strength Index (RSI)
  • ARRY 60.13
  • CRGX 46.65
  • Support Level
  • ARRY $5.80
  • CRGX $13.10
  • Resistance Level
  • ARRY $6.13
  • CRGX $14.94
  • Average True Range (ATR)
  • ARRY 0.36
  • CRGX 1.40
  • MACD
  • ARRY 0.13
  • CRGX 0.14
  • Stochastic Oscillator
  • ARRY 98.15
  • CRGX 59.63

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Its operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

Share on Social Networks: